Core Viewpoint - The company is preparing for its 2024 Annual General Meeting (AGM) scheduled for May 29, 2025, to discuss various proposals including financial reports, budget plans, and governance changes [5][6][18]. Meeting Procedures - The AGM will be held at the company's meeting room in Wuhan, with both on-site and online voting options available [5][6]. - Attendees must register 30 minutes prior to the meeting and present necessary identification documents [2][3]. - Voting will be conducted through a combination of on-site and online methods, with results announced after the meeting [2][5]. Proposals for Discussion - Proposal 1: Approval of the 2024 Annual Report and its summary, which has been prepared in accordance with relevant regulations [6][7]. - Proposal 2: Approval of the 2024 Board of Directors' Work Report, summarizing the main activities and achievements of the board [8]. - Proposal 3: Approval of the 2024 Supervisory Board's Work Report, detailing the supervisory activities conducted during the year [9]. - Proposal 4: Approval of the 2024 Independent Directors' Work Report, summarizing the independent directors' contributions [9]. - Proposal 5: Approval of the 2024 Financial Settlement Report, providing a comprehensive overview of the company's financial status [10]. - Proposal 6: Approval of the 2025 Financial Budget Report, projecting a revenue growth rate of 30% to 60% for the upcoming year [12]. - Proposal 7: Approval of the 2024 Profit Distribution Plan, proposing a cash dividend of 3.50 yuan per 10 shares, totaling approximately 35.04 million yuan [13]. - Proposal 8: Renewal of the external audit firm for the 2025 fiscal year, with the firm being Tianzhi International Accounting Firm [14]. - Proposal 11: Approval for the company and its subsidiaries to apply for a comprehensive credit limit of up to 1 billion yuan [18]. - Proposal 12: Proposal to abolish the Supervisory Board and amend the company's articles of association to enhance governance [19]. Financial Performance - In 2024, the company achieved a revenue of 873.13 million yuan, a year-on-year increase of 26.23%, while the net profit attributable to shareholders decreased by 15.03% to 112.75 million yuan [23]. - The total assets of the company reached 1.55 billion yuan, reflecting a growth of 25.01% compared to the previous year [23]. Governance Changes - The company plans to eliminate the Supervisory Board, transferring its responsibilities to the Audit Committee of the Board of Directors to streamline governance [19][20]. - The company will revise its governance documents to improve operational efficiency and compliance with updated regulations [20][21].

Core Viewpoint - The 2024 Annual General Meeting of Hangzhou Aotai Biotechnology Co., Ltd. is set to ensure the rights of shareholders and maintain order during the meeting, with specific procedures outlined for attendance, voting, and participation [1][2][3]. Group 1: Meeting Procedures - Shareholders or their proxies must arrive 30 minutes before the meeting to sign in and present necessary identification [2]. - Only authorized personnel, including shareholders, directors, supervisors, and invited guests, are allowed to enter the meeting venue [1][2]. - Shareholders have the right to speak, inquire, and vote during the meeting, but must adhere to the agenda and time limits for speaking [2][3]. Group 2: Voting Mechanism - The meeting will utilize a combination of on-site and online voting, with specific timeframes for each method [5][9]. - Shareholders must express their opinions on each voting item as "agree," "disagree," or "abstain," and any errors in voting will be considered as abstentions [3][4]. Group 3: Financial Performance - In 2024, the company achieved a revenue of 866.58 million yuan, representing a 14.83% increase from 2023 [41]. - The net profit attributable to shareholders was 302.47 million yuan, with a significant increase in net profit excluding non-recurring gains and losses by 61.67% [41][42]. - The company’s basic earnings per share rose to 3.82 yuan, marking a 67.54% increase compared to the previous year [41][42]. Group 4: Governance and Oversight - The board of directors held eight meetings during the reporting period, ensuring compliance with legal and regulatory requirements [14][17]. - The supervisory board conducted oversight of the company's operations and financial status, confirming that all activities adhered to legal standards [35][36]. - Independent directors played a crucial role in enhancing decision-making quality and risk management through their expertise [28].